Clinical and translational results of a phase I study, tocilizumab plus gemcitabine/nab-paclitaxel in patient with gemcitabine/nab-paclitaxel-refractory metastatic pancreatic cancer

被引：0
|
作者：
Mitsunaga, Shuichi [1 ]
Ikeda, Masafumi [1 ]
Aoki, Kazunori [2 ]
Yamaguchi, Kyoko [3 ]
Sawada, Noriaki [4 ]
Fujii, Etsuko [4 ]
Nishidate, Masanobu [4 ]
Fujitomo, Takashi [4 ]
Mizuno, Hideaki [4 ]
Kayukawa, Yoko [4 ]
Kato, Atsuhiko [5 ]
Makikawa, Mayu [3 ]
Imaoka, Hiroshi [1 ]
Sasaki, Mitsuhito [1 ]
Watanabe, Kazuo [1 ]
Tsunoda, Hiroyuki [4 ]
Terao, Kimio [3 ]
Ochiai, Atsushi [1 ]
机构：
[1] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[2] Natl Canc Ctr, Tokyo, Japan
[3] Chugai Pharmaceut Co Ltd, Tokyo, Japan
[4] Chugai Pharmaceut Co Ltd, Kamakura, Kanagawa, Japan
[5] Chugai Pharmaceut Co Ltd, Shizuoka, Japan
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT565
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A Retrospective Study of Gemcitabine Plus Nab-Paclitaxel for Advanced Pancreatic Cancer Refractory to Gemcitabine Monotherapy
    Nishioka, Mariko
    Okano, Naohiro
    Wakabayashi, Masashi
    Ikeno, Takashi
    Hayashi, Masato
    Mizutani, Tomonori
    Nagashima, Fumio
    Furuse, Junji
    ANTICANCER RESEARCH, 2024, 44 (03) : 1233 - 1239
  • [2] Comparison of gemcitabine plus nab-paclitaxel and FOLFIRINOX in metastatic pancreatic cancer
    Han, Sung Yong
    Kim, Dong Uk
    Seol, Young Mi
    Kim, Suk
    Lee, Nam Kyung
    Hong, Seung Baek
    Seo, Hyung-Il
    WORLD JOURNAL OF CLINICAL CASES, 2020, 8 (17) : 3718 - 3729
  • [3] Comparison of gemcitabine plus nab-paclitaxel and FOLFIRINOX in metastatic pancreatic cancer
    Sung Yong Han
    Dong Uk Kim
    Young Mi Seol
    Suk Kim
    Nam Kyung Lee
    Seung Baek Hong
    Hyung-Il Seo
    World Journal of Clinical Cases, 2020, (17) : 3718 - 3729
  • [4] A phase I trial of nab-paclitaxel, gemcitabine, and capecitabine for metastatic pancreatic cancer
    Andrew H. Ko
    Thach-Giao Truong
    Emily Kantoff
    Kimberly A. Jones
    Elizabeth Dito
    Anna Ong
    Margaret A. Tempero
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 875 - 881
  • [5] Efficacy and safety of Nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer
    Filipazzi, V.
    Dalu, D.
    Isabella, L.
    Tosca, N.
    Ferrario, S.
    Gambaro, A.
    Somma, L.
    Fasola, C.
    Pellegrini, I.
    Bombonati, G.
    Curcio, R.
    Damiani, E.
    Cattaneo, M. T.
    ANNALS OF ONCOLOGY, 2017, 28
  • [6] nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: Real life
    Cidon, E. Una
    Alonso, P.
    ANNALS OF ONCOLOGY, 2020, 31 : S109 - S109
  • [7] A phase I trial of nab-paclitaxel, gemcitabine, and capecitabine for metastatic pancreatic cancer
    Ko, Andrew H.
    Truong, Thach-Giao
    Kantoff, Emily
    Jones, Kimberly A.
    Dito, Elizabeth
    Ong, Anna
    Tempero, Margaret A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (06) : 875 - 881
  • [8] Increased PD-L1 expression levels were observed on both tumor cells and macrophages by tocilizumab plus gemcitabine/nab-paclitaxel treatment in gemcitabine/nab-paclitaxel-refractory metastatic pancreatic cancer patients
    Yamaguchi, Kyoko
    Fujii, Etsuko
    Mitsunaga, Shuichi
    Sawada, Noriaki
    Ikeda, Masafumi
    Fujitomo, Takashi
    Mizuno, Hideaki
    Kayukawa, Yoko
    Makikawa, Mayu
    Aoki, Kazunori
    Imaoka, Hiroshi
    Sasaki, Mitsuhito
    Watanabe, Kazuo
    Kato, Atsukiko
    Tsunoda, Hiroyuki
    Terao, Kimio
    Ochiai, Atsushi
    CANCER RESEARCH, 2022, 82 (12)
  • [9] A phase I study of intraperitoneal paclitaxel combined with gemcitabine plus nab-paclitaxel for pancreatic cancer with peritoneal metastasis
    Naminatsu Takahara
    Yousuke Nakai
    Hironori Ishigami
    Kei Saito
    Tatsuya Sato
    Ryunosuke Hakuta
    Kazunaga Ishigaki
    Tomotaka Saito
    Tsuyoshi Hamada
    Suguru Mizuno
    Hirofumi Kogure
    Hiroharu Yamashita
    Hiroyuki Isayama
    Yasuyuki Seto
    Kazuhiko Koike
    Investigational New Drugs, 2021, 39 : 175 - 181
  • [10] A phase I study of intraperitoneal paclitaxel combined with gemcitabine plus nab-paclitaxel for pancreatic cancer with peritoneal metastasis
    Takahara, Naminatsu
    Nakai, Yousuke
    Ishigami, Hironori
    Saito, Kei
    Sato, Tatsuya
    Hakuta, Ryunosuke
    Ishigaki, Kazunaga
    Saito, Tomotaka
    Hamada, Tsuyoshi
    Mizuno, Suguru
    Kogure, Hirofumi
    Yamashita, Hiroharu
    Isayama, Hiroyuki
    Seto, Yasuyuki
    Koike, Kazuhiko
    INVESTIGATIONAL NEW DRUGS, 2021, 39 (01) : 175 - 181
12345